Summary & Overview
CPT 90666: Preservative-Free Pandemic Influenza Vaccine, Split Virus
CPT code 90666 denotes a preservative-free, split-virus influenza vaccine administered intramuscularly to immunize against a pandemic influenza strain. This vaccine product is clinically important for large-scale immunization efforts during pandemic events and for providers documenting specific vaccine formulations. Clear coding supports inventory tracking, public health reporting, and accurate payment for vaccine administration.
Key payers in this national overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for this vaccine code, typical sites of service where it is administered, and which payers commonly cover pandemic influenza immunizations. The publication also outlines common billing modifiers associated with vaccine services and notes where input data was not provided.
The analysis is designed to help billing managers, immunization program leads, and policy analysts understand how CPT code 90666 maps to clinical use and payer coverage expectations. It highlights operational implications for outpatient clinics, physician offices, and public health vaccination sites, and summarizes the types of benchmarks and policy updates that are relevant for pandemic vaccine coding and reimbursement. Data not available in the input is identified where applicable.
Billing Code Overview
CPT code 90666 describes a preservative-free influenza vaccine formulated from a split virus and administered intramuscularly to protect against a pandemic influenza strain. The service represents vaccination aimed at active immunization against the specified pandemic influenza virus.
Service type: Immunization / Vaccine administration
Typical site of service: Outpatient clinic, physician office, public health clinic, or other ambulatory care settings
Clinical & Coding Specifications
Clinical Context
A 42-year-old immunocompetent adult presents to a primary care clinic during a declared influenza pandemic season seeking vaccination. The patient has no acute febrile illness, consents to immunization, and reports no history of severe allergic reaction to influenza vaccines. The clinic nurse verifies eligibility, reviews contraindications and precautions, obtains informed consent, documents lot number/manufacturer, and administers a single intramuscular injection of the preservative‑free, split-virus pandemic influenza vaccine coded as 90666. Post‑vaccination, the patient is observed for 15 minutes for immediate adverse reactions, and the immunization is recorded in the electronic medical record and state immunization registry. Typical sites of service include outpatient primary care clinics, community vaccination centers, occupational health clinics, and mass immunization sites. Common clinical workflow steps are patient screening, vaccine preparation using aseptic technique, intramuscular administration (deltoid for adults), documentation of vaccine details, provision of vaccine information statement, and brief post‑vaccine observation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard service | Applied when the vaccine administration has no unusual circumstances and no other modifier is required. |
| Reduced services | Used if a reduced or partial vaccine dose is administered (rare for standard influenza vaccination) or if circumstances limit provision of full service.